Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Investigation|December 1, 1987
On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIaK Furihata, D J Nugent, A Bissonette, et al.
Community Dentistry and Oral Epidemiology|April 13, 2001
A proposed method for assessing the quality of sealants--the CCC Sealant Evaluation SystemC Deery, H E Fyffe, Z J Nugent, et al.
Biochimica Et Biophysica Acta|August 3, 2007
Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2Yann Cheli, Sachiko Kanaji, Beatrice Jacquelin, et al.
Community Dentistry and Oral Epidemiology|January 14, 2000
Effect of diagnostic threshold on the validity and reliability of epidemiological caries diagnosis using the Dundee Selectable Threshold Method for caries diagnosis (DSTM)H E Fyffe, C Deery, Z J Nugent, et al.
Community Dentistry and Oral Epidemiology|January 14, 2000
In vitro validity of the Dundee Selectable Threshold Method for caries diagnosis (DSTM)H E Fyffe, C Deery, Z J Nugent, et al.
Cancer Genetics|March 11, 2017
Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndromeJeffrey S Buzby, Shirley A Williams, Lana Schaffer, et al.
Caries Research|October 3, 2000
A randomised controlled trial of the caries-preventive efficacy of a chlorhexidine-containing varnish in high-caries-risk adolescentsA H Forgie, M Paterson, C M Pine, et al.
Journal of Dentistry|April 28, 2000
General dental practitioners diagnostic and treatment decisions related to fissure sealed surfacesC Deery, H E Fyffe, Z J Nugent, et al.
British Dental Journal|August 28, 1999
The dental caries status of Scottish adolescents reported to be regular attenders. Initial results from a primary dental care based research networkC Deery, H E Fyffe, N M Nuttall, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2017
Estimating the potential cost of a high dose immune tolerance induction (ITI) therapy relative to the cost of a combined therapy of a low dose ITI therapy with bypassing agent prophylaxisG Kenet, A Oladapo, J D Epstein, et al.
Pageof 19